Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2019 | 01-2019 | 10-2018 | 07-2018 | 04-2018 | |
| Sales | 250 | 0 | 0 | 363 | 750 |
| Gross Profit | 250 | N/A | 0 | 363 | 750 |
| Operating Expenses | 2,843 | 4,984 | 5,408 | 5,968 | 2,151 |
| Operating Income | -2,593 | -4,984 | -5,408 | -5,606 | -1,401 |
| Other Income | 18 | 17 | 16 | 12 | 9 |
| Pre-tax Income | -2,575 | -4,967 | -5,392 | -5,594 | -1,393 |
| Net Income Continuous | -2,575 | -4,967 | -5,392 | -5,594 | -1,393 |
| Minority Interests | -37 | -85 | -89 | -117 | -14 |
| Net Income | $-2,538 | $-4,882 | $-5,303 | $-5,477 | $-1,379 |
| EPS Basic Total Ops | -0.13 | -0.25 | -0.30 | -0.30 | -0.08 |
| EPS Basic Continuous Ops | -0.13 | -0.26 | -0.31 | -0.30 | -0.08 |
| EPS Diluted Total Ops | -0.13 | -0.25 | -0.30 | -0.30 | -0.08 |
| EPS Diluted Continuous Ops | -0.13 | -0.26 | -0.31 | -0.30 | -0.08 |
| EBITDA(a) | $-2,456 | $-4,726 | $-5,320 | $-5,519 | $-1,317 |